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The inability to purify and culture astrocytes has
long hindered studies of their function. Whereas
astrocyte progenitor cells can be cultured from
neonatal brain, culture of mature astrocytes from
postnatal brain has not been possible. Here, we
report a new method to prospectively purify astro-
cytes by immunopanning. These astrocytes undergo
apoptosis in culture, but vascular cells and HBEGF
promote their survival in serum-free culture. We
found that some developing astrocytes normally
undergo apoptosis in vivo and that the vast majority
of astrocytes contact blood vessels, suggesting
that astrocytes are matched to blood vessels by
competing for vascular-derived trophic factors such
as HBEGF. Compared to traditional astrocyte cul-
tures, the gene profiles of the cultured purified
postnatal astrocytes much more closely resemble
those of in vivo astrocytes. Although these astro-
cytes strongly promote synapse formation and func-
tion, they do not secrete glutamate in response to
stimulation.
INTRODUCTION
Astrocytes are a major cellular constituent of the central nervous
system (CNS) outnumbering neurons in humans (Nedergaard
et al., 2003). Long thought to play primarily passive support
roles in the nervous system, recent evidence has highlighted
their importance in the formation, function, and elimination of
synapses (Eroglu and Barres, 2010). Despite these advances,
our understanding of astrocyte development and function, and
their signaling interactions with other cell types both in health
and disease, is still rudimentary.
As neurons are reliant on astrocyte-derived trophic support,
the functions of astrocytes with respect to neurons cannot be
uncovered merely by deleting them. However, progress in
understanding astrocyte biology has been stymied by lack of
techniques to study the functions of these cells in vitro. An impor-tant advance was the development of an astrocyte culture prep-
aration from rodent neonatal brains (McCarthy and de Vellis,
1980). Nearly all studies of astrocyte function since then have
exploited this culture preparation. In this paper, astrocytes
prepared using this method will be referred to as MD-astrocytes.
Much has been learned about neuron-glial interactions from this
method, but there are several limitations to its use. First, it is not
prospective and isolation of astrocytes involves many steps
extending over a week or more. Prospective isolation refers to
the direct selection and isolation of a specific cell, without indi-
rect steps extending over days or weeks. Second, while adult
astrocytes in vivo exhibit limited division (Haas et al., 1970; Skoff
and Knapp, 1991) and are highly process-bearing, MD-astro-
cytes divide rapidly and continuously, being able to be passaged
for many months, and lack processes, being flat and fibroblast-
like in morphology. Third, MD-astrocytes can only be prepared
from neonatal brains at a timewhen their generation is just begin-
ning. Few viable astrocytes can be obtained from postnatal or
adult brain suspensions, when mature astrocytes are present
in vivo. Fourth, it has recently been shown that MD-astrocytes
have a gene expression profile that differs significantly from
acutely isolated postnatal day 7 (P7) and P16 astrocytes (Cahoy
et al., 2008) and adult in vivo astrocytes (Doyle et al., 2008).
In addition, MD-astrocytes must be obtained by culture in an
undefined, serum-containingmedia. This is highly nonphysiolog-
ical, as most serum proteins are unable to cross the blood-brain
barrier and likely profoundly alter astrocyte properties (see
Discussion).
In this paper, we describe a new immunopanning method for
prospectively isolating astrocytes from rodent CNS tissue. We
have successfully isolated astrocytes from P1–P18 rats. Unlike
the previous McCarthy and de Vellis method of astrocyte prepa-
ration, where cells were prepared by a series of steps extending
over a week, we selected the astrocytes directly in a rapid isola-
tion procedure that was completed in 1 day. We also report
the development of a defined, serum-free medium that enables
the survival of the purified astrocytes in long-term culture.
Compared to MD-astrocytes, these immunopanned astrocytes,
which we refer to in this paper as IP-astrocytes, maintain gene
profiles in culture that much more closely mimic their acutely
purified state. Lastly using this new IP-astrocytes preparation,
we begin to unravel some of the fundamental functional proper-
ties of astrocytes.Neuron 71, 799–811, September 8, 2011 ª2011 Elsevier Inc. 799
Figure 1. Establishment of an Immunopanning Protocol for Rat
Astrocytes
(A) Cortical suspensions were passed over successive panning plates to
remove endothelial cells and microglia (BSL-1), microglia and macrophages
(secondary only plate), microglia (CD45), oligodendrocyte precursor cells (O4),
and finally a positive panning plate for astrocytes (ITGB5).
(B) Purity of IP-astrocytes validated by RT-PCR and (C) immunostaining with
GFAP. Before immunopanning, the whole cell brain suspension contained
25.1% GFAP+ cells, after immunopanning, the isolated cells were 98.7%
GFAP+.
(D) ITGB5 was present on all astrocytes. All cells in cortical cell suspensions
that were GFAP+ were also ITGB5+ (arrowheads).
(E) Astrocytes are positive for the apoptotic marker Annexin V.
(F) MD-astrocytes had flat and fibroblast-like morphologies at 14DIV.
(G) IP-astrocytes cultured with HBEGF for 14DIV were healthy and extended
multiple processes.
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Purification of Astrocytes from the Postnatal Rat Cortex
We applied immunopanning techniques we have previously
used to purify other major cell types of the central nervous
system (CNS) (Barres et al., 1988, 1992) to isolate astrocytes.
Due to the lack of known astrocyte-specific surface antigens,
immunopanning of astrocytes has previously been impossible.
We used the gene profiling data from Cahoy et al. (2008) to
select candidates expressed by astrocytes, then picked candi-
dates for which specific monoclonal antibodies directed against
surface epitopes, such as EGFR, FGFR3, and CD9, were avail-
able. We identified integrin beta 5 (itgb5) as highly expressed
and an astrocyte-specific gene suitable for immunopanning.
Itgb5 is expressed highly in acutely purified mouse astrocytes
both postnatally and in adult brain and was successful at puri-
fying astrocytes from CNS rat cortex. Yield obtained after P14
fell rapidly because of the difficulty of extracting astrocytes
viably (data not shown). This was not a significant limitation as
astrocytes reach their plateau number between postnatal day
7 and 10 in rodent brain, a time by which their gene expression
profiles are nearly indistinguishable from their adult gene
profiles, providing evidence that the gene profiles of acutely iso-
lated astrocytes very closely resemble in vivo cortical astrocyte
gene profiles (Doyle et al., 2008).
We used a succession of negative immunopanning plates to
remove other cell types from the dissociated cortical suspension
including microglia, macrophages, endothelial cells, and oligo-
dendrocyte precursor cells (OPCs) (Figure 1A). We then used
a final panning plate coated with the ITGB5monoclonal antibody
to select for astrocytes. We validated the purity of IP-astrocytes
with RT-PCR against a battery of cell type-specific markers such
as Bruno-like 4 (Brunol4) for neurons (identified to be highly
neuron specific; Cahoy et al., 2008), chemokine (C-X3-C motif)
receptor (CX3CR1) for microglia, and occludin (ocln) for endo-
thelial cells (Figure 1B). Before purification, the cortical suspen-
sion contained 25.1% GFAP+ cells, 24.9% microglia and endo-
thelial cells, 8.4% oligodendrocytes, 31.7% neurons and 6.6%
OPCs or pericytes as determined by immunostaining single
cell cortical suspensions (data not shown). After isolation,
98.7% of the cells were GFAP+, indicating the high degree of
purity of the IP-astrocytes (Figures 1B and 1C).
To assess if all or just a subset of IP-astrocytes express
ITGB5, we immunostained cortical suspensions with ITGB5
and GFAP antibodies and quantified the number of GFAP+ cells
that were also ITGB5+. 95.2% ± 6.2% of GFAP+ cells were also
ITGB5+, indicating that we have the ability to isolate the majority
of the GFAP-expressing cells from the rat cortex (Figure 1D).
The yield of purified astrocytes at P7 was approximately 10%
of all cortical cells and 50% of all astrocytes in the starting
suspension.
Identification of HBEGF as a Trophic Factor
for Astrocytes In Vitro
Plating of IP-astrocytes P7 in serum-free media without any
growth factors led to death of the majority of astrocytes by
apoptosis within 40 hr as verified by staining with Annexin V,
a marker of apoptosis (Figure 1E).800 Neuron 71, 799–811, September 8, 2011 ª2011 Elsevier Inc.We thus sought to identify the trophic factor(s) that IP-astro-
cytes require for survival in vitro with the aid of our gene profiling
data set. We generated a list of receptors expressed on the
surface of astrocytes and cross-referenced this list with growth
factors expressed by the major cell types in the brain and gener-
ated a list of candidates to test (Cahoy et al., 2008; Daneman
et al., 2010).
Figure 2. P7 Astrocytes Require Trophic Factors for Survival or Die
by Apoptosis
(A) Addition of 5 or 10 ng/ml of HBEGF or 10 ng/ml TGFa significantly (p <
0.001) promoted IP-astrocyte survival. Neither 10 ng/ml CNTF nor T3 signifi-
cantly increased survival of IP-astrocytes.
(B) AG1478 (AG), did not affect basal survival of astrocytes, but at 10 mM and
30 mM, significantly inhibited the effect of 5 ng/ml HBEGF (HBEGF) not
observed in control conditions with DMSO (p < 0.001).
(C) 1 mg/ml of Wnt7a is a trophic factor for astrocytes (**p < 0.01), but the effect
was not significantly additive with 5 ng/ml HBEGF. Values on x axis are
in ng/ml.
(D) Feeder layers of astrocytes, endothelial cells and pericytes produced
soluble trophic factors that significantly promoted the survival of astrocytes
(***p < 0.001). 30 mM AG1478 (AG) negated the survival-promoting effect of
astrocytes and partially of endothelial cells, but not pericytes (*p < 0.05).
(E) IP-astrocytes P7 grown in inserts at densities higher than 10,000 cells/insert
kept IP-astrocytes P7 alive.
(F) Mock depletion of ACMwith goat anti-Gg13 IgG did not negate the survival-
promoting effect of ACM. Depletion of ACM with goat anti-HBEGF IgG
negated the survival-promoting effect of ACM.
(G) Western blot analysis revealed that both mouse astrocytes and rat IP-
astrocytes P7 expressed EGFR.
(H) ECM and P1 ACM contained high levels of HBEGF, P7 ACM contained
lower levels and none in PCM. Top blot: low exposure, bottom blot: high
exposure. Error bars represent SEM.
Also see Figure S1.
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low density in a defined, serum-free base media with 0.5 mg/ml
of aphidicolin to inhibit cell division and assessed the ability of
individual growth factors to promote the survival of astrocytes
after 2 days in vitro (DIV). As 13% of astrocytes divided every
2 days (see Figure S1A available online and see below), aphidi-
colin, an inhibitor of the cell cycle, was used to enable accurate
determination of survival independently of division (Hughes and
Cook, 1996). Aphidicolin itself did not significantly affect the
survival of astrocytes (Figure S1B).
We testedmany candidates from the list of cognate ligands for
astrocyte receptors. However, these ligands did not confer
significant, reliable, or robust survivability. Among those tested
were ciliary neurotrophic factor (CNTF) and thyroid hormone
(T3) (Figure 2A), oncostatinM, sonic hedgehog, fibroblast growth
factor 9 (FGF9), interleukin-11 (IL-11), brain-derived neurotro-
phic factor (BDNF), pleiotrophin, Wnt3a, Wnt5a, platelet-derived
trophic factor BB, transforming growth factor b1 and 2 (data not
shown).
We found that 5 ng/ml of heparin-binding epidermal growth
factor (HBEGF) was effective at keeping astrocytes alive com-
pared to base conditions. HBEGF was very potent and consis-
tently able to promote survival of astrocytes in serum-free
culture (41.1% ± 3.2% astrocytes survived, p < 0.001; Figures
2A and S1F) for as long as 2 weeks and the cells extended
multiple processes (Figure 1G). HBEGF promoted the survival
of about 40%–60% of the isolated IP-astrocytes. HBEGF is a
member of the epidermal growth factor (EGF) family of growth
factors (Citri and Yarden, 2006). As such, we also tested the
survival-promoting ability of other EGF familymembers. 10 ng/ml
of transforming growth factor alpha (TGFa) (41.6%± 4.5% astro-
cytes survived, p < 0.001; Figure 2A) was as effective as HBEGF,
but this was not additive (data not shown). Amphiregulin,
however, was ineffective (Figure S1C).
HBEGF is a ligand for EGFR, erbB3, and erbB4 (Citri and
Yarden, 2006). Acutely purified mouse IP-astrocytes express
egfr and erbb2 (Cahoy et al., 2008). ErbB2 is not believed
to bind to any ligands but functions as a preferred heterodi-
meric coreceptor for other erbB receptors (Klapper et al.,
1999; Citri and Yarden, 2006). We verified that acutely isolated
mouse and rat IP-astrocytes express EGFR by western blotting
(Figure 2G). With immunostaining, we found that 92.6% ±
2.4% of eGFP+ cortical astrocytes at P6 in brain sections
were EGFR+, suggesting that they are receptive to HBEGF
signaling (Figure 3A). We used a specific EGFR tyrosine kinase
inhibitor, AG1478, to test if EGFR was the receptor mediating
survival in vitro (Gan et al., 2007). Concentrations of 10 mM
and 30 mM was sufficient to negate the effect of HBEGF,
providing further evidence that EGFR is the signaling receptor
for HBEGF that promotes the survival of astrocytes in vitro.
AG1478 itself was not detrimental to baseline cell survival
(Figure 2B).
We also found that Wnt7a at 1 mg/ml was effective at
promoting astrocyte survival (35.9%± 3.7%astrocytes survived,
p < 0.05), but the effect was not additive with HBEGF (37.0% ±
2.8% astrocytes survived; Figure 2C). As the effect of HBEGF
was robust and reliable, we focused the rest of the work in this
paper on HBEGF.Neuron 71, 799–811, September 8, 2011 ª2011 Elsevier Inc. 801
Figure 3. Astrocytes Express EGFR, Contact Blood Vessels, and Die
by Apoptosis In Vivo
(A) Immunohistochemical staining for EGFR in P6 Aldh1L1-eGFPmice showed
that majority of cortical astrocytes expressed EGFR (white arrowheads =
EGFR+,Aldh1L1-eGFP+).
(B and C) All hippocampal astrocytes at P14 (n = 23) and adult (n = 22) con-
tacted blood vessels. (B) P14 astrocytes sent out long processes that con-
tacted but not ensheathed blood vessels (white arrows). (C) Full ensheathe-
ment was observed in the adult.
(D and E) MADM-labeling sparsely labels astrocytes eGFP+ in the brain. Blood
vessels were stained with BSL-1 and eGFP+ astrocytes of the cortex visualized
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To see if astrocytes themselves could secrete signals that
promote their own survival, we assessed IP-astrocyte P7
survival with an IP-astrocyte P7 feeder layer. We found that
IP-astrocytes P7 produced a soluble autocrine trophic factor
that could keep other astrocytes alive (48.1% ± 0.8% astrocytes
survived, p < 0.001). This factor acted via EGFR as the effect was
significantly reduced by addition of AG1478 (23.0% ± 2.4%
astrocytes survived, p < 0.001) (Figure 2D). In line with this
result, when IP-astrocytes were plated at high densities either
in inserts or on coverslips, they produced enough trophic factors
to keep other astrocytes alive (Figures 2E and S1E).
Astrocytes have endfeet that make contact with blood vessels
and thus contact both endothelial cells and pericytes. To test if
vascular cells promoted astrocyte survival, we used feeder
layers of endothelial cells, pericytes, and a combination of peri-
cytes and endothelial cells to assess if these cells secreted
a factor that kept IP-astrocytes P7 alive. Pericytes significantly
promoted IP-astrocyte P7 survival (46.8% ± 4.3% astrocytes
survived, p < 0.001; Figures 2D, S1D, and S1M), but this effect
was insensitive to AG1478 (36.8% ± 7.3% astrocytes survived,
p < 0.05; Figure 2D). Endothelial cells were effective at keeping
IP-astrocytes P7 alive (49.0% ± 2.5% astrocytes survived, p <
0.001; Figures 2D, S1D, and S1N), and this effect was signifi-
cantly reducedwith AG1478 (30.9%± 2.8%astrocytes survived,
p < 0.001; Figure 2D). The combination of pericytes and endo-
thelial cells (33.2% ± 7.1% astrocytes survived, p < 0.001) had
the highest percentage of astrocytes bearing four or more
processes (Figures S1G and S1K–S1P) but did not confer
more survivability than endothelial cells (33.7%± 5.5%astrocyte
survived) or pericytes (42.9% ± 4.3% astrocytes survived) alone
(Figure S1D). Endothelial cells and astrocytes both express
hbegf mRNA (Cahoy et al., 2008, Daneman et al., 2010). Our
results suggest that the predominant factor produced by these
two cell types is likely to be HBEGF acting via EGFR, but peri-
cytes produce an unidentified trophic factor(s) that confers
survivability via a distinct signaling pathway. Consistent with
this, we found that endothelial cell conditioned media (ECM)
and IP-astrocyte P1 conditioned media (P1 ACM) contained
high levels of HBEGF, but IP-astrocytes P7 conditioned media
(P7 ACM; Figure 2H; high exposure) contained low levels and
pericyte conditioned media (PCM) did not contain HBEGF (Fig-
ure 2H). Depletion of P7 ACMwith goat anti-HBEGF IgG negated
the survival-promoting effect of P7 ACM, whereas P7 ACM
treated with an irrelevant control antibody, goat anti-Gg13 IgG,
retained full survival-promoting activity (Figure 2F).
As we have demonstrated that vascular cells strongly
promoted astrocyte survival in vitro, we next asked whether
survival of astrocytes in vivo might be dependent upon vascular
contact. We used two methods to investigate if every astrocytewith confocal microscopy. Thirty of thirty-one astrocytes visualized contacted
blood vessels.
(F and G) Quantification of immunohistochemical staining with activated
caspase 3 (red) in Aldh1L1-eGFP (green) mice and colocalization with
condensed nuclei visualized with DAPI (blue) (arrowheads) revealed that
astrocyte apoptosis was observed at P6. (G) Immunostaining of apoptotic
astrocytes in P6 Aldh1L1-eGFP mice. Error bars represent SEM.
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jected DiI into blood vessels to delineate the vessels (or used
DIC optics) and used patch-clamping to dye-fill astrocytes in
100 mm slices of P14 and adult rats. We found that 100% of
dye-filled astrocytes in both P14 (n = 23) and adult rats (n = 22)
had endfeet that contacted blood vessels. At P14, astrocytes
often extended long thin processes with an endfoot that con-
tacted the blood vessel. Full ensheathement is completed by
adulthood (Figures 3B and 3C). We also used an unbiased
approach to sparsely label astrocytes in the cortex using mosaic
analysis of double markers (MADM) in mice (Zong et al., 2005).
hGFAP-Cre was used to drive interchromosomal recombination
in cells with MADM-targeted chromosomes. We imaged 31
astrocytes in 100 mm sections and costained with BSL-1 to label
blood vessels and found that 30 astrocytes contacted blood
vessels at P14 (Figures 3D and 3E). Together, we conclude
that after the bulk of astrocytes have been generated, the
majority of astrocytes contact blood vessels.
We hypothesized that if astrocytes are matched to blood
vessels for survival during development, astrocytes that are
overgenerated and fail to establish a contact with endothelial
cells may undergo apoptosis because of failure to obtain needed
trophic support. By examining cryosections of developing post-
natal brains from Aldh1L1-eGFPGENSATmice, in whichmost or
all astrocytes express green fluorescent protein (Cahoy et al.,
2008), immunostaining with the apoptotic marker activated cas-
pase 3 and visualizing condensed nuclei, we found that the
number of apoptotic astrocytes observed in vivo peaked at P6
and sharply decreased with age thereafter (Figures 3F and 3G).
Death of astrocytes shortly after their generation and the
elevated expression of hbegf mRNA in endothelial cells
compared to astrocytes (Cahoy et al., 2008, Daneman et al.,
2010) support the hypothesis that astrocytes may require
vascular cell-derived trophic support.
IP-Astrocytes P7 Divide More Slowly Compared
to MD-Astrocytes
MD-astrocytes show remarkable proliferative ability and can be
passaged repeatedly overmanymonths. In contrast, most astro-
cyte proliferation in vivo is largely complete by P14 (Skoff and
Knapp, 1991). To directly compare the proliferative capacities
of MD and IP-astrocytes P7, we plated dissociated single cells
at low density in a defined, serum-free media containing HBEGF
and counted clones at 1, 3, and 7DIV (Figures S1Q–S1S). MD-
astrocytes displayed a much higher proliferative capacity, 75%
of them dividing once every 1.4 days by 7DIV. In contrast, 71%
of IP-astrocytes divided less thanonce every 3 days (Figure S1S).
Thus IP-astrocytes have a more modest ability to divide
compared with MD-astrocytes, this is more in line with what is
expected in vivo (Skoff and Knapp 1991).
Gene Expression of IP-Astrocytes Is Closer to that
of Cortical Astrocytes In Vivo Than MD-Astrocytes
Using gene profiling, we determined if gene expression of
cultured IP-astrocytes was more similar to that of acutely puri-
fied astrocytes, compared toMD-astrocytes. Total RNAwas iso-
lated from acutely purified astrocytes from P1 and P7 rat brains
(IP-astrocytes P1 and P7) and from acutely isolated cellscultured for 7DIV with HBEGF (IP-astrocytes P1 and P7 7DIV,
respectively) and from MD-astrocytes (McCarthy and de Vellis,
1980).
RT-PCRwith cell-type specific primers was used to assess the
purity of the isolated RNA. We usedGFAP, brunol4,MBP, occlu-
din,CX3CR1 asmentioned above, as well as chondroitin proteo-
glycan sulfate 4 (CSPG4) for OPCs and pericytes.MD-astrocytes
consistently had some neuron contamination because of the
high percentage of contaminating neural stem cells (Hildebrand
et al., 1997; Figure 4A). This was not observed in IP-astrocyte
cultures.
IP-astrocytes P1 and P7 7DIV cells had an expression profile
resembling their acutely isolated counterparts, where only 118
and 54 genes respectively differed significantly (p < 0.05). In
contrast, MD-astrocyte expression profiles were significantly
different from that of acutely purified cells (Table 1; Figure 4B).
With a very stringent statistical test (moderated t test) and post-
test (Bonferroni correction) to identify the most significant
changes, we found that 547 and 729 genes were significantly
different (p < 0.05) between acute IP-astrocytes P1 or P7 cells
andMD-astrocytes, respectively. These results strongly suggest
that by gene expression, cultured IP-astrocytes are more similar
to cortical astrocytes in vivo.
Only 54 genes out of over 31,000 genes differed significantly
between acute IP-astrocytes P7 and IP-astrocytes P7 7DIV
(p < 0.05). Of these, 51 genes were higher in acute cells than in
culture (Table 1). This is unsurprising as in culture, many signals
and cell-cell interactions are missing hence, many signaling
pathways would be turned off in the absence of the initiating
ligands. We generated tables of the top 30 genes that differed
significantly (p < 0.05) and R8-fold different between cultured
IP-astrocytes and their acutely isolated counterparts (Tables
S1 and S2). As several genes were turned off in both cultured
IP-astrocytes P1 and P7 cells, there is likely a common signal
in the brain regulating the expression of these genes at both
ages that is absent in the defined serum-free culture media.
To understand the significance of the differentially expressed
genes, we used ingenuity pathway analysis (IPA) to generate
lists of pathways that are activated in acutely isolated astrocytes
but are off in the cultured cells. Two pathways that were turned
off in P7 astrocytes upon culture were the Wnt and Notch path-
ways (Table S3).
We also found that many genes involved in modulating the cell
cycle such as ccnb1, cdkn1a, and ccnd1 were much higher in
MD-astrocytes versus cultured IP-astrocytes P7. Canonical
pathways significantly higher in MD-astrocytes compared to
IP-astrocytes were those involved in G2/MDNA damage, cyclins
and cell cycle regulation, and G1/S checkpoint regulation (p <
0.05). In contrast, no pathways involved in cell cycle regulation
were higher in cultured IP-astrocytes P7 compared to MD-astro-
cytes. This pathway analysis result is in line with what we
observe with regards to the higher proliferative capacity of
MD-astrocytes.
Understanding the Effect of Serum on Astrocytes
Unlike IP-astrocytes that are cultured in serum-free media, MD-
astrocytes must be cultured in serum right after isolation, hence
the gene expression differences could be caused by serumNeuron 71, 799–811, September 8, 2011 ª2011 Elsevier Inc. 803
Figure 4. Comparison of IP-Astrocyte Expression Profiles with MD-
Astrocytes
(A) Purity was assessed by RT-PCR with major cell type markers. MD-astro-
cytes have neuronal contamination not observed in IP-astrocytes whether
acute or cultured.
(B) Heat map of 15,960 genes where gene expression exceeds 200 in at least
one sample. Acutely isolated IP-astrocytes at P1 and P7 (IP-ast P1, P7), IP-
Table 1. Comparison of Number of Genes that Differ between













p < 0.05 729 547 54 118
p < 0.001 369 254 21 45
8-fold change
and p < 0.05
432 300 41 48
8-fold change
and p < 0.001
290 195 21 45
Fewer differences exist between acutely isolated astrocytes (IP-ast P1
and P7) and their cultured counterparts cultured for 7DIV (IP-ast P1
and P7 7DIV) than MD-astrocytes. See also Tables S1 and S2.
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induced by serum in IP-astrocytes, we cultured IP-astrocytes
right after isolation in MD-astrocyte growth media for 7 days
(10% serum). At 7 days, total RNAwas either collected (IP-astro-
cytes P7 7DIV serum) or the serum replaced with base media
containing HBEGF for an additional 7 days before collecting the
RNA for gene profiling analysis (IP-astros P7 14DIV withdraw).
Three hundred sixty-five genes were induced in the IP-astro-
cytes by serum (Figure 4C); however, few of these corresponded
to genes expressed by the MD-astrocytes. Of the top 30
genes induced by serum in IP-astrocytes, 8 of 30 genes were
expressed highly (>1000) in MD-astrocytes and 8 of 30 were
moderately expressed (>200 but < 1000; Table 2). The other 14
genes induced by serum in IP-astrocytes P7 were not expressed
by MD-astrocytes. In addition, the serum induced genes did not
revert back to the levels observed in IP-astrocytes P7 7DIV. 302
of the 365 serum-induced genes continued to be expressed
after serumwithdrawal. Additionally, of the pathways in IP-astro-
cytes P7 7DIV significantly induced by serum (p < 0.05), 16 of 28
remained active after serum withdrawal (Tables S4 and S5).
Together, our data shows that differences between MD-astro-
cytes and IP-astrocytes cannot be explained by serum exposure
alone and that serum exposure causes lasting gene expression
changes that persist after serum withdrawal.
Confirming Functional Properties of Astrocytes
in Culture
The much closer match of cultured IP-astrocyte gene profiles to
those of acutely purified astrocytes indicates that IP-astrocyteastrocytes that have been cultured in HBEGF for 7 days (IP-ast P1, P7 7DIV)
and MD-astrocytes gene expression was normalized and plotted on a log2
color scale. Cooler colors represent low expression and warm colors the
converse. MD-astrocytes profiles are distinct from IP-astrocytes and cultured
IP-astrocytes are closer in their profiles to their acutely isolated counterparts.
(C) Heat map showing expression levels of 365 serum-induced genes across
samples. IP-astrocytes P7 were treated for 7 days immediately after isolation
with 10% serum and either processed for RNA (IP-ast P7 7DIV serum) or the
serum withdrawn and cells cultured for an additional 7 days (IP-ast P7 14DIV
w/draw) and compared to IP-ast. P7 7DIV cultured in basemedia with HBEGF,
acutely isolated IP-ast P7 and MD-astrocytes. Serum induction did not cause
IP-astrocytes to exhibit a profile like MD-Astrocytes and serum withdrawal did
not cause reversion of the serum-induced genes.
Also see Tables S1–S5.
Table 2. Top 30 Genes Induced by Serum in cultured IP-Astrocytes P7











1 1372011_at 1,898 1,893 1,568 126 21 91
2 1370019_at Sult1a1 sulfotransferase family, cytosolic,
1A, phenol-preferring, member 1
358 5,715 11,358 551 73 78
3 1367661_at S100a6 S100 calcium binding protein A6 14,339 13,447 11,898 4,368 172 78
4 1370973_at Scn7a sodium channel, voltage-gated,
type VII, alpha
398 3,895 6,137 3,325 59 66
5 1376311_at Ntng1 netrin G1 1,073 1,143 317 83 18 64
6 1387659_at Gda guanine deaminase 2,251 2,821 2,652 149 51 55
7 1393696_at Fibin fin bud initiation factor homolog
(zebrafish)
30 1,138 1,330 97 24 48
8 1368420_at Cp ceruloplasmin 437 3,194 8,813 587 72 44
9 1372219_at Tpm2 tropomyosin 2, beta 2,157 4,922 3,119 978 126 39
10 1390024_at 348 4,110 7,582 947 107 38
11 1372599_at Mgst2 microsomal glutathione
S-transferase 2
581 1,194 861 256 32 38
12 1370952_at Gstm2 glutathione S-transferase mu 2 213 2,530 3,986 283 71 36
13 1383875_at Upk1b uroplakin 1B 29 750 684 181 21 35
14 1379584_at 267 519 220 40 15 34
15 1370902_at Akr1b8 aldo-keto reductase family 1,
member B8
121 943 130 164 28 34
16 1367592_at Tnnt2 troponin T type 2 (cardiac) 91 1,217 4,746 249 37 33
17 1373628_at 82 2,539 771 349 82 31
18 1391450_at Loxl2 lysyl oxidase-like 2 724 1478 474 225 49 30
19 1384707_at Scara5 scavenger receptor class A,
member 5 (putative)
21 1,056 1,467 133 37 29
20 1368014_at Ptges prostaglandin E synthase 62 1,183 279 45 42 28
21 1374284_at Rassf4 Ras association (RalGDS/AF-6)
domain family member 4
3,327 2,743 1,455 1,255 98 28
22 1383916_at Tbx15 T-box 15 19 1,223 1,207 265 45 27
23 1383456_at 18 558 437 102 21 27
24 1374172_at Col8a2 collagen, type VIII, alpha 2 121 4,376 4,359 1,628 166 26
25 1368868_at Akap12 A kinase (PRKA) anchor protein 12 1,863 2,409 854 227 92 26
26 1373727_at Fibin fin bud initiation factor homolog
(zebrafish)
107 1,573 2,580 230 62 26
27 1374477_at Prrx2 paired related homeobox 2 96 1,496 708 229 59 25
28 1369074_at Slc38a4 solute carrier family 38, member 4 12 540 136 71 22 25
29 1368171_at Lox lysyl oxidase 4,727 4,537 3,651 698 186 24
30 1393891_at Col8a1 collagen, type VIII, alpha 1 152 2,865 723 373 119 24
IP-astrocytes P7 cells were treated with 10% serum for 7 days and either processed for total RNA (IP-ast P7 7DIV serum) or the media exchanged for
HBEGFwithout serum for an additional 7 days (IP-ast P7 14DIVw/draw). Gene expression was compared toMD-astrocytes, acutely isolated P7 (IP-ast
P7) cells, and P7 cells cultured for 7 days in HBEGF (IP-ast P7 7DIV). 13/30 genes induced by serum were not expressed by MD-astrocytes and only
17/30 were more than moderately expressed (>200). Reversion of gene expression levels to baseline levels did not occur after serum withdrawal. See
also Tables S4 and S5.
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We therefore assessed whether IP-astrocytes exhibited well-
characterized astrocytic functions in culture.
MD-astrocytes promote CNS neuron survival in culture
(Banker 1980; Wagner et al., 2006). We asked if the cultured
IP-astrocytes could similarly promote CNS neuronal survival.
We purified P5 retinal ganglion cells (RGCs) by immunopanningas described in Barres et al. (1998) and added conditioned
media (CM) from P1 (IP-astrocytes P1 ACM) or P7 astrocytes
(IP-astrocytes P7 ACM). RGC growth media (RGC GM) and
MD-astrocytes CM (MD-ACM) were used as positive controls.
In the absence of any growth factors or astrocyte-derived
media, fewer than 5% of RGCs survive. Both P1 ACM and
P7 ACM (*p < 0.05, **p < 0.01), were as strongly effective atNeuron 71, 799–811, September 8, 2011 ª2011 Elsevier Inc. 805
Figure 5. IP-Astrocytes in Culture Retained Func-
tional Properties
(A and B) IP-astrocyte ACM was as capable of keeping
neurons alive as MD-astrocytes was. The neurons were
healthy and extended multiple processes. Majority of
neurons died in the absence of trophic support. ACM
derived from IP-astrocytes P1 and P7 (IP-ast P1 and P7
ACM), MD-astrocytes (MD-ACM), and a positive control of
RGC growth media was used.
(C) Coomassie gel of ACM used to ensure equivalent
protein loading.
(D) MD-astrocytes produced much higher levels of
APOE (D), APP (E), and TSP2 (F), compared to P1 and
P7ACM.P1ACMdidnot containdetectable levelsof TSP2.
(G) Synaptogenesis was quantified by assessing colocali-
zation of presynaptic marker bassoon (green) and post-
synaptic marker homer (red) with ImageJ.
(H) IP-ast P1 and P7 feeder layers were as effective at
inducing structural synapses as MD-astrocytes were.
Without an astrocyte feeder layer, few synapses were
observed (control) (**p < 0.01, *p < 0.05).
(I) Sample traces of whole-cell patch clamp recordings
from RGCs made in the presence of TTX. Few mEPSCs
were observed without feeder layer of astrocytes (Ctrl).
(J and K) Frequency and amplitude of mEPSCs recorded
increased significantly withMD-astrocytes, IP-astros P1 or
P7 feeder layers (p < 0.05).
(L) IP-astros P1 and P7 caused a shift in cumulative
amplitude of mEPSCs to a similar level as MD-astrocytes.
Error bars represent SEM.
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(Figures 5A and 5B).
Astrocytes are known to secrete many proteins that have been
shown to be important in the CNS for instance apolipoprotein E
(APOE), amyloid precursor protein (APP) and thrombospondin 2
(TSP2) (Farber et al., 1995; Mauch et al., 2001; Christopherson
et al., 2005). We verified with western blotting that ACM from
MD-astrocytes and IP-astros P1 and P7 contained these three
proteins. A Coomassie stain was used to verify that equivalent
amounts of protein were loaded (Figure 5C). Both P1 ACM and
P7 ACM contained APOE and APP. However, only P7 ACM con-
tained TSP2. This differential protein expression at different
astrocyte ages shows that we can use this new culture system
to tease apart the roles of astrocytes at different developmental
time points based on our ability to purify astrocytes at different
ages. Interestingly, MD-ACM contained much higher levels of
APP, TSP2, and APOE, molecules known to be critical regulators
of synapse formation and function (Figures 5D–5F). These results
questionedwhether IP-astrocytes were as capable asMD-astro-
cytes at inducing the formation of structural and functional
synapses in culture.806 Neuron 71, 799–811, September 8, 2011 ª2011 Elsevier Inc.To directly address this question, we next
tested the ability of IP-astrocytes to induce
structural synapses by exposing RGCs to
feeder layers of P1, P7 IP-astrocytes, MD-astro-
cytes or a control with no astrocytes. Neuronal
cultureswere stained for bassoon, a presynaptic
marker and homer, a postsynaptic marker (Fig-ure 5G). The number of colocalized puncta in each condition
were quantified and we have plotted the number of colocalized
puncta as a fold change over control (Figure 5H). There were
significant increases in synapse number over control with MD-
astrocytes (fold change = 3.12, p < 0.01), P1 (fold change =
2.57, p < 0.05), and P7 (fold change = 2.86, p < 0.01) IP-astrocyte
inserts (Figures 5G and 5H). Thus, IP-astrocytes are as capable
of inducing structural synapses in RGC cultures as MD astro-
cytes are.
Structural synapses are not indicative of functional synapses,
thus we analyzed synaptic activity of the RGCs in the presence
of a feeder layer of astrocytes. Previous studies have shown
that the number of functional synapses increases significantly
with an MD-astrocyte feeder layer (Ullian et al., 2001). We
found that both the frequency and amplitude of miniature
excitatory postsynaptic currents (mEPSCs) increased signifi-
cantly and to a comparable degree with feeder layers of IP-
astrocytes P1 or P7, to that observed with an MD-astrocyte
feeder layer (Figures 5I–5L). Taken together, these results
show that IP-astrocytes retain functional properties character-
istic of astrocytes.
Figure 6. Calcium Responses to Different
Stimuli Differ between MD-Astrocytes and
IP-Astrocytes, and MD-Astrocytes Are
Contaminated with Several Cell Types;
Astrocytes Do Not Exhibit Glutamate
Release in Response to ATP In Vitro
(A–F) Stimuli was added at 120 s (black arrow).
Graphs of calcium responses from 5 different cells.
Graph axes are average intensity (AI, arbitrary
units) versus time (s). (A) Both MD-astrocytes and
(B) IP-astrocytes P7 responded to ATP with
increased calcium oscillations. (C) MD-astrocytes
responded (83.4% ± 4.4%, n = 118, p < 0.0001)
robustly to 50 mMKCl with increased frequency of
oscillations. (D) No calcium response was
observed with KCl addition in IP-astrocyte
cultures. (E) No response of cells due to media
addition was observed in IP-astrocytes treated
with 10% serum for 4 days. (F) Cultured IP-astro-
cytes treated with 10% serum caused a significant
number of astrocytes to respond to KCl (53.3% ±
7.4%, n = 209, p < 0.001).
(G) Glutamate was readily released by neurons
with KCl stimulation (***p < 0.001). Releasewas not
detected in IP- nor MD-astrocytes treated with
HBEGF orMD-astrocyte growthmedia (AGM,10%
serum) in response to 100 mM ATP.
(H–J) MD-astrocyte cultures were contaminated
with oligodendrocytes (MBP), OPCs and pericytes
(NG2), and neurons (TUJ1) whereas minimal
contamination was observed in cultures of IP-
astrocytes. Error bars represent SEM.
Also see Figure S2.
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Intracellular calcium oscillations have been observed in astro-
cytes in vivo and are considered an important functional property
of astrocytes and may aid in regulation of blood flow or
neural activity (Nimmerjahn et al., 2009). Several stimuli have
been implicated in initiating calcium waves in MD-astrocytes.
We used calcium imaging with Fluo-4 to investigate if IP-astro-
cytes exhibit calcium rises in response to glutamate, adenosine,
potassium chloride (KCl), and ATP and if the nature of their
response was similar to MD astrocytes (Cornell-Bell et al.,
1990; Jensen and Chiu, 1991; Kimelberg et al., 1997; Pilitsis
and Kimelberg, 1998).
Few calcium oscillations were observed at rest in IP-astro-
cytes, contrary to MD-astrocytes. A single cell in confluent
cultures of P7 IP-astrocytes would respond independently of
its neighbors. Such isolated and spontaneous firing of astrocytes
has previously been observed in brain slices (Nett et al., 2002;
Parri and Crunelli, 2003). In contrast, rhythmic calcium activity
and regular spontaneous activity were observed in MD-astro-
cytes grown in the same media as cultured IP-astrocytes P7
(Figures 6A and 6C).
Both MD-astrocytes and IP-astrocytes responded to 10 mM
of adenosine (100% of MD-astrocytes, 89.6% ± 5.5% of IP-
astrocytes; Figures S2C and S2D), 50 mM of glutamate (100%
of MD-astrocytes, 88.1% ± 7.9% of IP-astrocytes; Figures S2E
and S2F), and 100 mM of ATP (94.4% ± 5.5% of MD-astrocytes,92.5% ± 1.5% of IP-astrocytes; Figures 6A and 6B) with
increased frequency of calcium oscillations and/or amplitude
of calciumoscillations. Both have severalP2X andP2Y receptors
and adora1 and adora2b receptors and thus can respond to
these stimuli. Both MD and IP-astrocytes express mRNA for ion-
otropic glutamate receptors, but only the latter have metabo-
tropic receptors (accession record number, GSE26066). Thus,
the second phase calcium response observed with glutamate
in IP-astrocytes after a period of quiescence, could be a metab-
otropic response. This was not observed in MD-astrocytes.
KCl has been reported to depolarize MD-astrocytes and
induce vesicular release of gliotransmitters in a calcium-depen-
dent manner (Paluzzi et al., 2007). We found that 50 mM KCl
caused more MD-astrocytes to respond (83.3% ± 4.4%, n =
275 cells, p < 0.0001; Figure 6C). In contrast, IP-astrocytes
consistently failed to respond to KCl (0.3%± 0.2%, n = 749 cells;
Figure 6D). Control conditions yielded few responses in both
MD-astrocytes (17.9% ± 7.4% cells respond, n = 118 cells)
and IP-astrocytes (4.5% ± 3.4% cells respond, n = 95 cells;
Figures S2A and S2B).
Immunostaining cultures after imaging with MBP, NG2, and
TUJ1 revealed high numbers of contaminating oligodendro-
cytes, OPCs and neurons in MD-astrocyte cultures (Figures
6H–6J) but not in IP-astrocyte cultures. To test if the response
of MD-astrocytes was an indirect consequence of neuronal
depolarization, we incubated MD-astrocyte cultures withNeuron 71, 799–811, September 8, 2011 ª2011 Elsevier Inc. 807
Neuron
Purification and Culture of Rodent Astrocytes100 nM bafilomycin-A1, an inhibitor of vacuolar-type ATPases,
to block neurotransmitter release by neurons (Zhou et al.,
2000; Nett et al., 2002). This did not eliminate MD-astrocyte
responses as 83.3% ± 5.1% of the cells still responded (n =
558), alter the level of neuronal contamination nor alter the
response to 100 mM ATP (Figures S2G–S2J). Interestingly, we
found that growing IP-astrocytes for 3 days in MD-astrocyte
growth media (AGM) containing 10% serum significantly
increased the percentage of IP-astrocytes (53.3% ± 7.4%, p <
0.001, n = 209 cells; Figure 6F) responding to KCl, compared
to control conditions of IP-astrocytes grown in AGM (18.9% ±
5.7%, n = 134 cells; Figure 6E). We found no increase in contam-
inating cell types in serum-treated IP-astrocytes cultures (data
not shown). These findings suggest that serum exposure alters
the properties and functions of astrocytes in culture and that
IP-astrocytes, based on their expression profiles and physi-
ology, are more representative of in vivo astrocytes.
Astrocytes Do Not Release Glutamate in Culture
in Response to ATP
Astrocytes have been reported to release glutamate both in vitro
and in vivo in response to stimuli such as ATP that elevate their
intracellular levels of calcium (Parpura et al., 1994, Pasti et al.,
1997, Hamilton and Attwell 2010). To investigate if IP-astrocytes
exhibit regulated release of glutamate, we used the sensitive
method of HPLC with tandem mass spectrometry analysis, to
detect glutamate in cultures of IP- and MD-astrocytes in
response to 100 mM of ATP. As a positive control, we stimulated
cultures of RGCs with KCl and readily detected glutamate
(1880 nM) in the media after 5mins of stimulation (p < 0.001
over unstimulated neurons). However, glutamate was not
detected in both IP- and MD-astrocytes cultured in HBEGF or
AGM in response to ATP (Figure 6G). Control experiments where
we loaded IP or MD-astrocytes for 5mins with 0.5 mM of gluta-
mate prior to stimulation did not lead to regulated release of
glutamate by IP- or MD-astrocytes (data not shown). Our results
demonstrate that under these conditions, ATP does not induce
glutamate release by astrocytes.
DISCUSSION
Wehave developed a technique that allows prospective purifica-
tion of astrocytes from the postnatal rat cortex, established
serum-free conditions that promote their survival in vitro, and
shown that their expression profiles in these cultures more
closely resemble that of cortical astrocytes in vivo than the tradi-
tional McCarthy-de Vellis preparation of cultured neonatal
astrocytes.
Astrocytes Can Be Prospectively Purified
from CNS Cell Suspensions
Cell purification provides a powerful method that enables the
study of the intrinsic properties of a cell type and its interactions
with other cell types. Despite their abundance in the CNS, study
of astrocytes has been hindered by the lack of a method for their
prospective purification. The McCarthy and de Vellis (1980)
method has been an invaluable method for isolation of neonatal
astrocyte-like cells, but it has been unclear if these cells are good808 Neuron 71, 799–811, September 8, 2011 ª2011 Elsevier Inc.models of astrocytes in vivo as their isolation was not prospec-
tive and involved passage in serum-containing medium. As
these MD-astrocytes can only be obtained from neonatal brain,
it has been speculated that these cells may bemore akin to radial
glia, astrocyte progenitor cells or reactive astrocytes. Indeed,
our recent gene profiling studies demonstrated that MD-astro-
cytes highly express hundreds of genes that are not normally
expressed in vivo (Cahoy et al., 2008). and in more recent work
we have found that their profiles indicate that they may be
a combination of reactive and developing astrocytes (J. Zama-
nian, L.C.F., and B.A.B., unpublished data).
Prospective purification is important as it ensures that the
selected astrocytes are representative of the whole population,
avoiding the selection of a minor subset. In the MD-astrocyte
preparation procedure, only a small percentage of astrocyte-
like cells in the starting neonatal suspension survive in culture
(our unpublished observations). Prospective purification also
avoids prolonged culture of the cells in serum, which can irre-
versibly alter the properties of the cells. By combining a series
of depletion panning steps to remove unwanted cell types
such as microglia followed by a selection step using a mono-
clonal antibody to integrin beta 5, we have been able to prospec-
tively isolate differentiated astrocytes from P1 to P18 rat brain
tissue at a purity of 99% and a yield of 50% of all astrocytes at
P7. Although we have focused on the isolation of rat astrocytes
in this work, we have developed a similar panning method to
purify astrocytes to greater than 95% purity from postnatal
mouse brain (Experimental Procedures). This will enable astro-
cyte isolation from mutant or diseased mice, further facilitating
the understanding of the functional role of astrocytes. Theoreti-
cally, this method can be extended to the purification of human
astrocytes by using an appropriate ITGB5 antibody.
Astrocytes Require Trophic Factors for Survival
It has long been thought that astrocytes, unlike other brain cell
types, may not need trophic signals to survive. Astrocytic cell
death was reported in the postnatal rat cerebellum (Soriano
et al., 1993; Krueger et al., 1995); however, as astrocytes are
phagocytic cells (al-Ali and al-Hussain, 1996), the presence of
apoptotic nuclei within astrocytes could be phagocytozed
apoptotic neurons. We have observed that majority of prospec-
tively isolated CNS astrocytes (IP-astrocytes) die within 40 hr by
apoptosis when cultured without any trophic factors and identi-
fied HBEGF and Wnt7a as effective at promoting significant
astrocyte survival in vitro. Previous studies have underlined the
necessity of EGFR for survival in the cortex; however, the rele-
vant ligand for EGFR has not been identified (Kornblum et al.,
1999; Wagner et al., 2006). Our finding that HBEGF strongly
promotes astrocyte survival in vitro, together with its high level
in vascular cells (Daneman et al., 2010), strongly suggests that
HBEGF is an excellent candidate for the ligand mediating astro-
cyte survival in vivo.
Do developing astrocytes compete for a limiting amount of
endogenous trophic factor as do developing neurons and oligo-
dendrocytes, which are matched to a limited number of target
cells and axons, respectively (Barres et al., 1992)? Indeed, we
have observed astrocytic apoptosis during the peak of astrogen-
esis in vivo. As we found that HBEGF is highly expressed by
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cyte survival, and that the majority of the astrocytes we analyzed
contacted blood vessels, we hypothesize that a similar matching
may occur between astrocytes and blood vessels. Excess,
unneeded astrocytes generatedwhere blood vessels are already
ensheathed by other astrocytes may undergo elimination by
apoptosis. This hypothesis can be tested in future experiments
by assessing whether astrocytes fail to survive in adult mice in
which blood vessels are eliminated by exposure to hyperoxia
(Ndubuizu et al., 2010).
Differentiated Astrocytes Have Only a Modest Ability
to Divide
It is generally thought that differentiated astrocytes retain a high
ability to proliferate. This hypothesis is based on the existence
of highly proliferative glial CNS tumors and as astrocytes in
MD-astrocyte cultures are so highly proliferative. However, we
show that prospectively purified postnatal astrocytes cultured
in HBEGF, a mitogenic signal, display only a modest ability to
proliferate, dividing once every 3 days, while MD-astrocytes
divide every 1.4 days. Even after astrocytes had reached their
plateau numbers in the CNS by about P14 (Skoff and Knapp
1991), we found that they still retained this modest ability to
divide (data not shown). Thus, most cortical astrocytes are not
terminally postmitotic, but have a modest ability to divide (Skoff
and Knapp, 1991), in keeping with recent findings on the limited
proliferation of reactive astrocytes after brain injury (J. Zamanian,
L.C.F., and B.A.B., unpublished data).
Prospectively Purified Immunopanned Astrocyte
Cultures as a New Preparation for Understanding
Astrocyte Function
The function of astrocytes has long been an intriguing mystery.
As neurons depend on astrocytes for their survival, it has not
been possible to get at their functional roles in vivo simply by
deleting them. Culture studies thus provide a powerful approach.
While MD-astrocytes have been a useful model system, we have
shown here they are not optimal models of in vivo differentiated,
more mature astrocytes. Therefore, in this report, we have
studied the functions of themore mature IP-astrocytes by cocul-
turing them with CNS neurons. We found that these astrocytes
strongly stimulated neuronal survival and formation of functional
synapses just as do theMD-astrocytes. In other cases, however,
we observed differences in the behavior of the MD- and IP-
astrocytes.
For instance, there are differing responses of MD-astrocytes
and IP-astrocytes to various stimuli such as glutamate and KCl
and we speculate that this could be due to serum exposure
and/or contaminating cells. In fact, we often observed sponta-
neous calcium activity in the absence of a stimulus in MD but
not IP-astrocytes. Similar calcium activity in astrocytes has
been observed in slices and has been shown to be dependent
on neuronal activity (Aguado et al., 2002; Kuga et al., 2011),
providing further evidence that observations made in cultures
of MD-astrocytes could be due to neuronal contamination.
The marked difference between the response of MD-astrocytes
and IP-astrocytes to KCl stimulation is striking. A robust
response is observed in MD-astrocytes but not IP-astrocytecultures, unless they were exposed to serum. Interestingly,
astrocytes in brain slices lacked a calcium response to KCl appli-
cation, but responded to neuronal depolarization by KCl applica-
tion due to neuronal glutamate release after a delay of several
seconds (Pasti et al., 1997). Thus, IP-astrocyte cultures have
a KCl response that is more representative of in vivo astrocytes,
further validating this new astrocyte preparation.
We therefore used IP-astrocyte cultures to investigate the
currently controversial issue of whether astrocytes are capable
of induced glutamate release. Several reports have suggested
that, rather than degrading glutamate, astrocytes in vitro and
in vivo can accumulate, store, and release glutamate in a regu-
lated manner (Hamilton and Attwell 2010). However, while we
could easily detect glutamate release from neurons, neither
MD- nor IP-astrocytes released detectable amounts of gluta-
mate when stimulated with ATP. We speculate that previous
reports that MD-astrocytes secrete glutamate in culture could
be due to variable levels of contaminating cells in these cultures.
As IP-astrocytes are cultured in a defined media, without
serum, and have gene profiles that closely resemble cortical
astrocytes in vivo, these cultures promise to be very useful in
understanding the fundamental properties of astrocytes. Many
interesting questions can now be studied. For instance, what
are the effects of stimulation of astrocytes with ligands of their
various highly expressed transmembrane receptors? What tran-
scriptional changes occur in astrocytes following sustained
increase in intracellular calcium levels during repetitive neuronal
stimulation? What are the interactions of astrocytes with
other cell types such as neurons and endothelial cells? What
are the signals that induce astrocytes to become reactive
glial cells, is gliosis a reversible phenotype, and what are the
functions of reactive astrocytes? Also, the ability to culture puri-
fied astrocytes will enable a metabolomics comparison of the
signals secreted by astrocytes, neurons, and oligodendrocytes,
enabling novel neuron-glial signals to be identified. Importantly,
our methods can be simplymodified to isolate human astrocytes
to compare the functional properties of rodent and human astro-
cytes directly. This will enable comparison of their ability to
induce synapse formation and function and elucidation of the
signals responsible, both in health and disease.
EXPERIMENTAL PROCEDURES
For detailed procedures, including detailed rodent panning protocol, see
Supplemental Information.
Tissue Dissociation
Six to ten postnatal Sprague-Dawley rat cortices were enzymatically then me-
chanically dissociated to produce single cells before passing over successive
negative panning plate to rid the cell suspension of microglia, endothelial cells,
OPCs before selecting for astrocytes with an ITGB5-coated plate.
Survival Assay and Culture Conditions of Immunopanned Astrocytes
For all survival studies, IP-astrocytes were cultured at 2,500 cells/coverslip in
a 24-well plate in a minimal media (see Supplemental Experimental Proce-
dures) with 0.5 mg/ml aphidicolin (Sigma A0781). Individual growth factors
were added to base media for testing. Survival was assayed 40 hr after plating
using the Live/Dead Kit (Invitrogen L3224). Three coverslips counted per
condition. Used one-way ANOVA with Bonferonni correction for statistics.
Error bars represent SEM.Neuron 71, 799–811, September 8, 2011 ª2011 Elsevier Inc. 809
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tion base media for 1 day before addition to freshly isolated IP-astrocytes to
assess survival.
Immunopanning with Mouse Astrocytes
We added 100 ml of 0.5 mg/ml sheep anti-ITGB5 (R&D Systems, AF3824) into
5–10 ml of cell suspension after negative panning steps and incubated the
cells for 30–40 min at 24C. Three milliliters of 100% FCS/10 ml media was
added and the cells spun at 1000 rpm for 10 min. The supernatant was dis-
carded and the cell pellet resuspended in 0.02% BSA and plated onto an
anti-sheep IgG-coated Petri dish.
Dye Filling of Astrocytes
Hippocampal astrocytes from P14 and adult rat were located in 100 mm thick
sections by IR-DIC and iontophoretically filled with 5% aq. Lucifer yellow.
Vessels were visualized with DIC (P14) or transcardial perfusion of DiI (adult).
The slices were imaged on an Olympus FV1000 using a 603 oil objective
(NA 1.40). Confocal volumes were analyzed and rendered using Imaris
(Bitplane).
Immunostaining of Brain Sections
Ten micrometer thick sagittal cryosections were immunostained with EGFR
(Millipore #06-847) or activated caspase 3 (BD PharMingen 559565) overnight
at 4C. Images were taken at 403 on a Zeiss Axiocam microscope.
One hundred micrometer MADM brain sections were stained with anti-GFP
(1:1,000, AbcamAB13970) and BSL-I (1:100, Vector labs, B-1105) for 3 days at
4C. Secondary antibodies were incubated at 4C, overnight. Images made
with a 633 Plan Apochromat oil objective on a LSM 510Meta Confocal scope.
Immunodepletion of ACM
P7 ACM was incubated overnight with anti-HBEGF (sc-1414) or goat anti-
Gg13 IgG (sc-26781) conjugated to Protein A/G beads then added to base
media to assess survival; three biological replicates; one-way ANOVA with
Bonferroni correction method. Error bars represent SEM.
Sample Preparation and Gene Expression Analysis
Total RNA isolated with QIAshredder and QIAGEN RNeasy Mini Kit. Used the
30 IVT Express kit for preparation of the RNA and the Rat Genome 230 2.0 Array
chip (Affymetrix, Santa Clara). Expression values were generated for our data-
sets using the RMA method with the ArrayStar program from DNASTAR, Inc.
All statistical analyses and clustering done with ArrayStar.
We filtered genes that had an expression value over 200 in any sample and
performed unsupervised hierarchical clustering on these 15,960 genes. To
calculate statistical values, we used a moderated t test with the Bonferroni
correction method.
Neuronal Survival and Synapse Formation Assays
Fifteenmicrograms of protein from IP- orMD-astrocyte CMwas added to RGC
minimal media. RGC growth media is RGC minimal media with 50 ng/ml of
BDNF (Peprotech 450-02), 10 ng/ml CNTF, 50 mg/ml insulin (Sigma I6634)
and B27 supplement. RGCs were purified as previously described (Barres
et al., 1988) and plated at 15,000 cells/well and survival was assessed after
3 days (n = 3).
RGCs were cultured for 7 days in RGC growth media and inserts of astro-
cytes added for 6 more days (n = 3). After 6 days, cells were fixed for 10 min
with 4% PFA and stained for Bassoon and Homer. Puncta Analyzer plugin
was used to quantify synapses in ImageJ. One-way ANOVA with Bonferonni
correction was used to calculate statistics. Error bars represent SEM.
Electrophysiology
Miniature excitatory postsynaptic currents (mEPSCs) were recorded by
whole-cell patch clamping RGCs at room temperature (18C–22C) at
a holding potential of 70 mV. The extracellular solution contained 140
NaCl, 2.5 CaCl2, 2 MgCl2, 2.5 KCl, 10 glucose, 1 NaH2PO4, and 10 HEPES
(pH 7.4) (in mM), plus TTX (1 mM) to isolate mEPSCs. Patch pipettes were
3–5 MU and the internal solution contained (in mM) 120 K-gluconate,
10 KCl, 10 EGTA, and 10 HEPES (pH 7.2). mEPSCs were recorded using810 Neuron 71, 799–811, September 8, 2011 ª2011 Elsevier Inc.pClamp software for Windows (Axon Instruments, Foster City, CA), and
were analyzed usingMini Analysis Program (SynaptoSoft, Decatur, GA) (n = 3).
Western Blotting
Blots were probed with rabbit anti-human EGFR (Cell Signaling 2232), mouse
anti-human actin (Abcam 8226), APOE, TSP2 and APP, and rabbit anti-rat
HBEGF antibody (kind gift from Prof. F. Zeng) were used. Pierce GelCode
Blue Stain reagent was used for Coomassie staining.
Quantitation of Glutamate
Astrocytes were cultured in either base media containing 5 ng/ml HBEGF or
MD-astrocyte growth media (AGM) containing 10% FCS. RGCs were grown
for 7 days in RGC. Cells were washed with HEPES-Buffered Ringers’ 33
before stimulation. One hundred micromolar of ATP was used for stimulation
and 100 mM of DL-TBOA used to block glutamate transporters. Two hundred
microliters of Ringer’s was added onto the cells and the cells incubated at
37C for 5min. One hundred fifty microliters of media was collected after
5 min and sent to Brains On-Line, LLC for quantitation by mass spectrometry.
ACCESSION NUMBERS
Raw .CEL files for all samples used for gene expression analysis in
the paper can be accessed via the NCBI Gene Expression Omnibus
(GEO) database at http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token =
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